跳至主要内容
临床试验/NCT01330459
NCT01330459已完成4 期

An Evaluation of Hydrocodone/Acetaminophen for Pain Control in First Trimester Surgical Abortion

Elizabeth Micks2 个研究点 分布在 1 个国家目标入组 121 人开始时间: 2011年2月最近更新:
适应症
干预措施
相关药物

试验速览

阶段
4 期
状态
已完成
发起方
入组人数
121
试验地点
2
主要终点
Patient Perception of Pain

研究概览

简要总结

The purpose of this study is to determine whether preoperatively administered hydrocodone/acetaminophen (HC/APAP) reduces pain during a first trimester surgical abortion.

详细描述

The investigators plan to conduct a double-blinded randomized placebo-controlled trial of 120 women undergoing elective first trimester surgical abortion. These women will be premedicated with either two tabs of 5/350 hydrocodone/acetaminophen or 2 tabs of a placebo. All subjects will receive ibuprofen and lorazepam preoperatively and a PCB. This study will examine the incremental benefit of HC/APAP over this standard medication regimen. Randomization will be stratified into two groups. Subjects less than 8 weeks gestation will comprise the early gestational age group. Subjects between 8 weeks 0 days and 10 weeks 6 days will comprise the late gestational age group. The investigators will be assessing patient perception of pain, nausea, satisfaction, and anxiety at multiple points during the clinic visit using 100-mm visual analogue scales (VAS).

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
Triple (Participant, Care Provider, Investigator)

入排标准

年龄范围
18 Years 至 65 Years(Adult, Older Adult)
性别
Female
接受健康志愿者

入选标准

  • Aged 18 years or older
  • Voluntarily requesting surgical pregnancy termination
  • Pregnancy with intrauterine gestational sac up to 10 weeks 6 days gestation, dated by ultrasound
  • Eligible for suction curettage
  • English or Spanish speaking
  • Good general health
  • Able and willing to give informed consent and agree to terms of the study

排除标准

  • Gestational ages 11 weeks or more
  • Incomplete abortion
  • Premedication with misoprostol
  • Use of any opioid medication within the past 7 days
  • Use of heroin within the past 7 days
  • Requested opioids or IV sedation prior to start of the procedure
  • Patients who refuse ibuprofen or lorazepam
  • Contraindications or allergies to HC/APAP, lidocaine, ibuprofen, or lorazepam
  • Significant medical problem necessitating inpatient procedure
  • Adnexal mass or tenderness on pelvic exam consistent with pelvic inflammatory disease
  • Known hepatic disease

研究组 & 干预措施

Hydrocodone/acetaminophen

Active Comparator

Subject will receive hydrocodone/acetaminophen 45-90 minutes prior to abortion procedure.

Subject will also recieve ibuprofen, lorazepam, and lidocaine 45-90 minutes prior to abortion procedure.

干预措施: Ibuprofen (Drug)

Placebo

Placebo Comparator

Subject will receive placebo 45-90 minutes prior to abortion procedure.

Subject will also recieve ibuprofen, lorazepam, and lidocaine 45-90 minutes prior to abortion procedure.

干预措施: Lidocaine (Drug)

Hydrocodone/acetaminophen

Active Comparator

Subject will receive hydrocodone/acetaminophen 45-90 minutes prior to abortion procedure.

Subject will also recieve ibuprofen, lorazepam, and lidocaine 45-90 minutes prior to abortion procedure.

干预措施: Hydrocodone/acetaminophen (Drug)

Hydrocodone/acetaminophen

Active Comparator

Subject will receive hydrocodone/acetaminophen 45-90 minutes prior to abortion procedure.

Subject will also recieve ibuprofen, lorazepam, and lidocaine 45-90 minutes prior to abortion procedure.

干预措施: Lorazepam (Drug)

Hydrocodone/acetaminophen

Active Comparator

Subject will receive hydrocodone/acetaminophen 45-90 minutes prior to abortion procedure.

Subject will also recieve ibuprofen, lorazepam, and lidocaine 45-90 minutes prior to abortion procedure.

干预措施: Lidocaine (Drug)

Placebo

Placebo Comparator

Subject will receive placebo 45-90 minutes prior to abortion procedure.

Subject will also recieve ibuprofen, lorazepam, and lidocaine 45-90 minutes prior to abortion procedure.

干预措施: Placebo (Drug)

Placebo

Placebo Comparator

Subject will receive placebo 45-90 minutes prior to abortion procedure.

Subject will also recieve ibuprofen, lorazepam, and lidocaine 45-90 minutes prior to abortion procedure.

干预措施: Ibuprofen (Drug)

Placebo

Placebo Comparator

Subject will receive placebo 45-90 minutes prior to abortion procedure.

Subject will also recieve ibuprofen, lorazepam, and lidocaine 45-90 minutes prior to abortion procedure.

干预措施: Lorazepam (Drug)

结局指标

主要结局

Patient Perception of Pain

时间窗: At time of uterine aspiration (baseline)

To determine whether HC/APAP, given in addition to a standard regimen of ibuprofen, lorazepam, and PCB, affects patient pain perception at the time of uterine aspiration, as measured by distance (mm) from the left of the 100 mm visual analog scale (VAS). The number 0 indicates no pain, and 100 indicates worst pain imaginable.

次要结局

  • Patient Perception of Pain During Cervical Dilation(During procedure (approximately 45-90 min after hydrocodone/acetaminophen or placebo, and within 5 minutes of procedure starting))
  • Satisfaction With Pain Control(30 minutes after completion of the procedure (which started 45-90 minutes after study drug administration))
  • Postoperative Nausea(30 minutes after completion of the procedure (which started 45-90 minutes after study drug administration))
  • Need for Additional Intraoperative and/or Postoperative Pain Medication(30 minutes after completion of the procedure (which started 45-90 minutes after study drug administration))

研究者

发起方
Elizabeth Micks
申办方类型
Other
责任方
Sponsor Investigator
主要研究者

Elizabeth Micks

Fellow in Family Planning

Oregon Health and Science University

研究点 (2)

Loading locations...

相似试验